Authors: Topol, CE Califf, RM Simes, RJ Van de Werf, F Diaz, R Paolasso, E Aylward, PE Keech, A Klein, W Piegas, L Tomov, I Armstrong, PW Widimsky, P Grande, P Halinen, M Vahanian, A Neuhaus, K Dimas, AP Preda, I Kristinsson, A Tzivoni, D Ardissino, D White, HD Madsen, S Sugrue, D Sadowski, Z Seabra-Gomes, R Apetrei, E Dalby, A Betriu, A Pfisterer, M Verheugt, F Fox, K Bates, ER Gibler, WB Granger, CB Harrington, RA Hochman, JS Holmes, DR Kleiman, NS Lee, KL Moliterno, DJ Newby, LK Ohman, EM Califf, R Newby, K Zillman, L Lee, K Lemons, P McCourt, B Campbell, C Tardiff, B Snapp, J Bassett, K Hodgson, P Hannan, K Kandzari, L Hawkins, S Hinman-Smith, E McDougal, M Raffetto, K Thompson, D Wehrle, T Ange, C Brown, R Grissom, G Heuckel, M McCall, J Pennachi, W Spychala, M Veasey, S Pullium, M Journey, T Quintero, K Mark, D Davidson-Ray, L Diner, L Nelson, C Sowers, C Webb, G Young, M Bhapkar, M Pacchiana, C Sparapani, R Tuttle, R Weaver, D Borzak, S Douthat, L Topol, E Moliterno, D Konczos, L Baishnab, R Baishnab, R Bakos, A Blashford, L Bratsch, J Brown, K Cadorini, E Carlson, J Clemmons, P DelValle, M Drabik, M Fu, G Gates, K Gibson, Y Heil, L Hill, N Klancar, R McHale, B Montague, E Pasca, N Pergi, L Randall, R Rosso, R Sankovich, K Smith, D Wisniewski, L Witkowski, M Zovkic, V Alexander, K Bhatt, D Brener, S Campbell, L Cho, L Cole, C Deedy, M Foody, J Gassler, J Ghaffari, S Haas, G Kapadia, S Lauer, M Lauer, MS Lincoff, M Lutton, S Marso, S Mukherjee, D Patel, V Penn, M Robbins, M Roe, M Sila, C Thamilarasan, M Wagner, G Armstrong, P Bestilny, S Van de Werf, F Budts, W Graux, S Luyten, A Simes, J Keech, A Kava, M Bower, T Chan, S Crampton, L Monro, C Nayak, M Parente, G Riley, V Wilton, D Aylward, P Dolan, S Thomas, C White, H Scott, M Frye, R Alpert, J Bertrand, M Ryan, T Fisher, L Asarch, L Smith, M Lim, L Bokslag, M Chiu, P Chung, J Collins, S Dougherty, C Guimaraes, D Hakim, Z Mathieson, J Montgomery, L Novotny, B Steiner, B Wittke, B

Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345